Non-biomedical sources for systematic reviews of pharmaceutical policy.
作者信息
Greyson Devon L
机构信息
Centre for Health Services and Policy Research, University of British Columbia, 201-2206 East Mall, Vancouver, BC, Canada V6T 1Z3.
出版信息
J Med Libr Assoc. 2010 Jan;98(1):85-7. doi: 10.3163/1536-5050.98.1.021.
Abstract
摘要
相似文献
1
Non-biomedical sources for systematic reviews of pharmaceutical policy.
J Med Libr Assoc. 2010 Jan;98(1):85-7. doi: 10.3163/1536-5050.98.1.021.
2
Copayment coupons undermine formularies.共付优惠券破坏了药品处方集。
Manag Care. 2011 Dec;20(12):63.
3
Canadian policy makers' views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers.加拿大政策制定者对涉及药品制造商机密折扣的药品报销合同的看法。
Health Policy. 2013 Oct;112(3):248-54. doi: 10.1016/j.healthpol.2013.05.022. Epub 2013 Jun 25.
4
Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.加拿大处方药直接面向消费者广告的十二年经验：一则警示故事。
PLoS One. 2009 May 27;4(5):e5699. doi: 10.1371/journal.pone.0005699.
5
Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.监管机构在针对消费者的药品广告中提出的投诉：三个不同国家的案例。
Res Social Adm Pharm. 2019 Oct;15(10):1274-1279. doi: 10.1016/j.sapharm.2018.12.001. Epub 2018 Dec 7.
6
US drug industry group launches campaign to defend pricing.
BMJ. 2016 Sep 9;354:i4902. doi: 10.1136/bmj.i4902.
7
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.治愈病态的制药体系：美国和加拿大的改革药方。
BMJ. 2018 May 17;361:k1039. doi: 10.1136/bmj.k1039.
8
Evidence and values: paying for end-of-life drugs in the British NHS.证据与价值观：在英国国民保健制度下为临终药物付费。
Health Econ Policy Law. 2012 Oct;7(4):393-409. doi: 10.1017/S1744133112000205.
9
Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians.促进处方药竞争的政策建议：美国医师学院立场文件。
Ann Intern Med. 2020 Dec 15;173(12):1002-1003. doi: 10.7326/M19-3773. Epub 2020 Sep 15.
10
How to Reduce Prescription Drug Prices: First, Do No Harm.如何降低处方药价格：首先，不要造成伤害。
Mo Med. 2020 Jan-Feb;117(1):14-15.
引用本文的文献
1
Systematic review searches must be systematic, comprehensive, and transparent: a critique of Perman et al.系统评价检索必须是系统的、全面的、透明的：对 Perman 等人的批判
BMC Public Health. 2019 Feb 4;19(1):153. doi: 10.1186/s12889-018-6275-y.
2
Roles for librarians in systematic reviews: a scoping review.图书馆员在系统评价中的作用：一项范围综述
J Med Libr Assoc. 2018 Jan;106(1):46-56. doi: 10.5195/jmla.2018.82. Epub 2018 Jan 2.
本文引用的文献
1
Comparison of tiered formularies and reference pricing policies: a systematic review.分层处方集与参考定价政策的比较：一项系统综述。
Open Med. 2009;3(3):e131-9. Epub 2009 Aug 4.
2
3
Economics methods in Cochrane systematic reviews of health promotion and public health related interventions.Cochrane系统评价中关于健康促进及公共卫生相关干预措施的经济学方法
BMC Med Res Methodol. 2006 Nov 15;6:55. doi: 10.1186/1471-2288-6-55.
4
Towards systematic reviews that inform health care management and policy-making.迈向为医疗保健管理和政策制定提供信息的系统评价。
J Health Serv Res Policy. 2005 Jul;10 Suppl 1:35-48. doi: 10.1258/1355819054308549.
5
Natural experiments: an underused tool for public health?自然实验：公共卫生领域未得到充分利用的工具？
Public Health. 2005 Sep;119(9):751-7. doi: 10.1016/j.puhe.2004.11.008.
6
Searching multiple databases for systematic reviews: added value or diminishing returns?在多个数据库中检索系统评价：附加值还是收益递减？
Complement Ther Med. 2004 Dec;12(4):228-32. doi: 10.1016/j.ctim.2004.09.003.
7
Beyond MEDLINE for literature searches.文献检索不限于医学期刊数据库。
J Nurs Scholarsh. 2003;35(2):177-82. doi: 10.1111/j.1547-5069.2003.00177.x.
8
Information retrieval in systematic reviews: challenges in the public health arena.系统评价中的信息检索：公共卫生领域的挑战
Am J Prev Med. 2000 May;18(4 Suppl):6-10. doi: 10.1016/s0749-3797(00)00135-5.
9
Why we need observational studies to evaluate the effectiveness of health care.为什么我们需要观察性研究来评估医疗保健的有效性。
BMJ. 1996 May 11;312(7040):1215-8. doi: 10.1136/bmj.312.7040.1215.
Zotero 插件